期刊文献+

恶性血液病合并肺部真菌感染的危险因素分析 被引量:5

Analysis of the risk factors of pulmonary fungal infections related to hematologic malignancies
下载PDF
导出
摘要 目的回顾性研究恶性血液病合并肺部真菌感染的危险因素。方法选择自1997年1月~2007年1月在我院诊断恶性血液病合并肺部真菌感染、细菌感染患者,对比分析其相关的危险因素,并进行统计学分析。结果共收集到符合条件的病例304例,其中真菌感染194例,占63.8%,细菌感染110例,占36.2%。单因素分析和Logistic多因素回归分析显示激素、晕轮征、既往真菌感染、ANC小于0.5×109/L持续10d以上、靠近胸膜的结节影、移植(免疫抑制剂使用)、化疗、广谱抗生素是恶性血液病合并肺部真菌感染的独立危险因素。结论恶性血液病合并肺部真菌感染具有多种危险因素,及早发现并及时进行抗真菌干预性治疗是非常必要的。 Objective To investigate the risk factors of pulmonary fungal infections related to hematologic malignancies. Methods A retrospective case-controlled study was conducted to analyze the patients with pulmonary fungal and bacterial infections in association with hematologic malignancies. The risk factors of pulmonary fungal infections related to hematologic malignancies were identified. Results Three hundred and four cases(194 of pulmonary fungal infections and 110 of pulmonary bacterial infections)were enrolled in this study. Univariate analysis and multivariate logistic regression show that such factors as corticosteroid, halo sign,previous fungal infections,ANC lower than 0.5×109/L for over 10 days, nodus near pleura,transplantation (immunodepressant use), chemotherapy, and broad spectrum antibiotics were all the independent risk factors of pulmonary fungal infections related to hematologic malignancies. Conclusion There are many risk factors for pulmonary fungal infections related to hematologic malignancies, and early identification of these factors for timely antifungal treatment is of much clinical significance.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2009年第12期2506-2509,共4页 Journal of Southern Medical University
基金 广东省科技计划项目(2008B030303014)
关键词 恶性血液病 肺部真菌感染 危险因素 hematologic malignancies pulmonary fungal infections risk factors
  • 相关文献

参考文献13

  • 1黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:423
  • 2Morrissey CO, Slavin MA. Antifungal strategies for managing invasive aspergillosis: The prospects for a pre-emptive treatment strategy[J]. Med Mycol, 2006 Sep; 44 Suppl: 333-48.
  • 3Cherif H, Kalin M, Bjorkholm M. Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment [J] ? Eur J Haematol, 2006 Octl; 77(4): 288-92.
  • 4钟慧.139例医院真菌感染与抗真菌药物应用分析[J].中华医院感染学杂志,2004,14(7):801-803. 被引量:49
  • 5Pitter D, Monod M, Suter PM, et al. Candida colonization and subsequent infections in critically ili surgical patients [J]. Ann Surg, 1994, 220(6): 751.
  • 6Christin I, Wysong DR, Meshulam T, et al. Mechanisms and target sites of damage in killing of Candida albicans hyphae by human polymorphonuclear neutrophils[J]. Infect Dis, 1997, 176: 1567-78.
  • 7王志永,姜尔烈,张平,王华,包宇实,王玫,冯四洲,韩明哲.异基因造血干细胞移植后侵袭性真菌感染及其危险因素分析[J].中国实验血液学杂志,2008,16(3):618-622. 被引量:8
  • 8Scott LJ, Simpson D. Voriconazole: a review of its use in the management of invasive fungal infections [J]. Drug, 2007, 67(2): 269-98.
  • 9O'Dormell MR, Schmidt GM, Tegmeier BR, et al. Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients {J]. J Clin Oncol, 1994, 12: 827-34.
  • 10Singh N, Paterson DL. Aspergillus infections in transplant recipients [J]. Clin Microbiol Rev, 2005, 18(1): 44-69.

二级参考文献16

  • 1黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:423
  • 2许兰平,纪宇,刘代红,陈育红,韩伟,刘开彦,黄晓军.造血干细胞移植后患者侵袭性真菌感染发生及危险因素分析[J].中华内科杂志,2007,46(6):486-489. 被引量:8
  • 3Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev,2005 ; 18:44.
  • 4Leather HL, Wingard JR. Is combination antifungal therapy for invasive aspergillosis a necessity in hematopoietic stem-cell transplant recipients? Curr Opin Infect Dis, 2006;19:371 -379.
  • 5Post MJ, Lass-Floerl C, Gastl G, et al. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients. Transpl Infect Dis, 2007 ;9:189 - 195.
  • 6Upton A. Kirby KA, Carpenter P, et al. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis, 2007 ;44: 531 -540.
  • 7Morgan J, Wannemuehler KA, Marr KA, et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol, 2005 ; 43 : S49 - S58.
  • 8O'Donnell MR, Schmidt GM, Tegtmeier BR, et al. Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. J Clin Oncol. 1994; 12:827 - 834.
  • 9Robertson M J. Larson RA. Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy. Am J Med. 1988 ;84:233 - 239.
  • 10Fukuda T, Boeckh M, Guthrie KA, et al. Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center. Biol Blood Marrow Transplant, 2004 ; 10:494 - 503.

共引文献473

同被引文献40

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部